{"transactions":[{"id":1282129,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-05T18:31:59.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":124714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":124714,"derivative":{"exercise_price":1.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":124714},"source":{"system":"sec-edgar","filing":"0001725160-25-000040","document":"wk-form4_1738798313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516025000040/wk-form4_1738798313.xml","form_type":"4"}},{"id":1282128,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-05T18:31:59.000Z","date":"2025-02-03","kind":"sale","planned":false,"acquired":false,"shares":13230,"price":1.7115,"value":22643.145,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person."}],"balance_after":1070784,"source":{"system":"sec-edgar","filing":"0001725160-25-000040","document":"wk-form4_1738798313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516025000040/wk-form4_1738798313.xml","form_type":"4"}},{"id":1282127,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-05T18:31:59.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":934041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1084014,"source":{"system":"sec-edgar","filing":"0001725160-25-000040","document":"wk-form4_1738798313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516025000040/wk-form4_1738798313.xml","form_type":"4"}},{"id":1659198,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T19:14:48.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options were granted to the Reporting Person in connection with Reporting Person's promotion to Chief Legal Officer, which became effective February 1, 2024. The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":90000,"derivative":{"exercise_price":11.69,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001725160-24-000032","document":"wk-form4_1707178473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516024000032/wk-form4_1707178473.xml","form_type":"4"}},{"id":1659197,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-05T19:14:48.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. The options are Reporting Person's annual equity grants, which reflect the market data for Reporting Person's role as Chief Legal Officer, a role to which she was promoted on February 1, 2024."}],"balance_after":112500,"derivative":{"exercise_price":11.69,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001725160-24-000032","document":"wk-form4_1707178473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516024000032/wk-form4_1707178473.xml","form_type":"4"}},{"id":1659196,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-05T19:14:48.000Z","date":"2024-02-02","kind":"sale","planned":false,"acquired":false,"shares":3310,"price":11.54,"value":38197.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $11.35 to $11.64. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":149973,"source":{"system":"sec-edgar","filing":"0001725160-24-000032","document":"wk-form4_1707178473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516024000032/wk-form4_1707178473.xml","form_type":"4"}},{"id":1659195,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-05T19:14:48.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":153283,"source":{"system":"sec-edgar","filing":"0001725160-24-000032","document":"wk-form4_1707178473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516024000032/wk-form4_1707178473.xml","form_type":"4"}},{"id":2038706,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-01T19:06:44.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":59217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date."}],"balance_after":59217,"derivative":{"exercise_price":23.65,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":59217},"source":{"system":"sec-edgar","filing":"0001725160-23-000016","document":"wf-form4_167529638915918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516023000016/wf-form4_167529638915918.xml","form_type":"4"}},{"id":2038705,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-01T19:06:44.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":40783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date."}],"balance_after":40783,"source":{"system":"sec-edgar","filing":"0001725160-23-000016","document":"wf-form4_167529638915918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516023000016/wf-form4_167529638915918.xml","form_type":"4"}},{"id":2199176,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-01T17:28:17.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":290500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted by the Issuer under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":290500,"derivative":{"exercise_price":28.82,"expiration_date":"2032-07-31","underlying":"Common Stock","underlying_shares":290500},"source":{"system":"sec-edgar","filing":"0001725160-22-000142","document":"wf-form4_165938928345083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000172516022000142/wf-form4_165938928345083.xml","form_type":"4"}},{"id":2355331,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-03T18:09:24.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options were granted by LogicBio Therapeutics, Inc. (the \"Company\") pursuant to its 2018 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Company on each vesting date."}],"balance_after":80000,"derivative":{"exercise_price":0.7,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-22-015817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000120919122015817/doc4.xml","form_type":"4"}},{"id":2705827,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":83561,"kind":"person","name":"Paul Andrea","position":1,"cik":"0001863130","reported_name":"Paul Andrea","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2021-05-19T16:12:33.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":165000,"derivative":{"exercise_price":4.72,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001209191-21-033994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863130/000120919121033994/doc4.xml","form_type":"4"}}]}